About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
Biosimilars
Current news
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2012
11.12.2012
Paediatric Regulation
26.11.2012
Industry faces tough task to meet EU API deadline
20.06.2012
Medicines UK Appoints New Chair
23.05.2012
Medicines UK Sustainability Action Plan 2012
23.05.2012
New Initiative On the Generic Pharmaceutical Industry
23.05.2012
SORRY, WORKSHOPS NOW FULL! Medicines UK to Host Patient Information and Labelling Workshops
23.05.2012
Speech made by Lord Howe at the AGM of Medicines UK on May 23, 2012
14.03.2012
Medicines UK Partners With MHRA to Improve Patient Safety Information
12.01.2012
IHP Recognise Medicines UK as Trusted Partner
Highlights
25.06.2020
Life Sciences Recovery Roadmap
16.06.2020
Reaction to dexamethasone treatment for Covid-19 patients
02.04.2020
Statement of intent for UK life sciences
25.03.2020
COVID-19 Medicines UK update
20.03.2020
Key worker welcome
18.03.2020
Covid-19 statement
04.03.2020
Response to today's CMA fines on anti-competitive agreements
06.02.2020
Reaction to the Government's document on the UK's approach to trade deals with non-EU nations